226 related articles for article (PubMed ID: 30565830)
1. The relationship between mesorectal grading and oncological outcome in rectal adenocarcinoma.
Silva-Velazco J; Stocchi L; Valente MA; Church JM; Liska D; Gorgun E; Kalady MF; Kessler H; Steele SR; Delaney CP
Colorectal Dis; 2019 Mar; 21(3):315-325. PubMed ID: 30565830
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with noncomplete mesorectal excision following surgery for rectal adenocarcinoma.
Sapci I; Velazco JS; Xhaja X; Aiello A; Gorgun E; Stocchi L; Delaney CP; Steele SR; Valente MA
Am J Surg; 2019 Mar; 217(3):465-468. PubMed ID: 30454839
[TBL] [Abstract][Full Text] [Related]
3. Mesorectal grades predict recurrences after curative resection for rectal cancer.
Maslekar S; Sharma A; Macdonald A; Gunn J; Monson JR; Hartley JE
Dis Colon Rectum; 2007 Feb; 50(2):168-75. PubMed ID: 17160574
[TBL] [Abstract][Full Text] [Related]
4. Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer.
Madbouly KM; Hussein AM; Abdelzaher E
Am J Surg; 2014 Sep; 208(3):332-41. PubMed ID: 24581995
[TBL] [Abstract][Full Text] [Related]
5. Local recurrence in patients treated for rectal cancer using total mesorectal excision or transection of mesorectum.
Vojnosanit Pregl; 2016 Oct; 73(10):927-33. PubMed ID: 29327910
[TBL] [Abstract][Full Text] [Related]
6. Suboptimal surgery and omission of neoadjuvant therapy for upper rectal cancer is associated with a high risk of local recurrence.
Bondeven P; Laurberg S; Hagemann-Madsen RH; Ginnerup Pedersen B
Colorectal Dis; 2015 Mar; 17(3):216-24. PubMed ID: 25510260
[TBL] [Abstract][Full Text] [Related]
7. Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial.
Rullier E; Vendrely V; Asselineau J; Rouanet P; Tuech JJ; Valverde A; de Chaisemartin C; Rivoire M; Trilling B; Jafari M; Portier G; Meunier B; Sieleznieff I; Bertrand M; Marchal F; Dubois A; Pocard M; Rullier A; Smith D; Frulio N; Frison E; Denost Q
Lancet Gastroenterol Hepatol; 2020 May; 5(5):465-474. PubMed ID: 32043980
[TBL] [Abstract][Full Text] [Related]
8. Factors that influence the adequacy of total mesorectal excision for rectal cancer.
Jeyarajah S; Sutton CD; Miller AS; Hemingway D;
Colorectal Dis; 2007 Nov; 9(9):808-15. PubMed ID: 17441969
[TBL] [Abstract][Full Text] [Related]
9. Partial Mesorectal Excision for Rectal Adenocarcinoma: Morbidity and Oncological Outcome.
Kanso F; Lefevre JH; Svrcek M; Chafai N; Parc Y; Tiret E
Clin Colorectal Cancer; 2016 Mar; 15(1):82-90.e1. PubMed ID: 26372333
[TBL] [Abstract][Full Text] [Related]
10. Oncological Outcomes After Robotic Proctectomy for Rectal Cancer: Analysis of a Prospective Database.
Sammour T; Malakorn S; Bednarski BK; Kaur H; Shin US; Messick C; You YN; Chang GJ
Ann Surg; 2018 Mar; 267(3):521-526. PubMed ID: 27997470
[TBL] [Abstract][Full Text] [Related]
11. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.
Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y;
Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of macroscopic completeness of mesorectal resection in rectal cancer.
Leite JS; Martins SC; Oliveira J; Cunha MF; Castro-Sousa F
Colorectal Dis; 2011 Apr; 13(4):381-6. PubMed ID: 20002696
[TBL] [Abstract][Full Text] [Related]
13. Surgical treatment of adenocarcinoma of the rectum.
Zaheer S; Pemberton JH; Farouk R; Dozois RR; Wolff BG; Ilstrup D
Ann Surg; 1998 Jun; 227(6):800-11. PubMed ID: 9637543
[TBL] [Abstract][Full Text] [Related]
14. Selective approach for upper rectal cancer treatment: total mesorectal excision and preoperative chemoradiation are seldom necessary.
Marinello FG; Frasson M; Baguena G; Flor-Lorente B; Cervantes A; Roselló S; Espí A; García-Granero E
Dis Colon Rectum; 2015 Jun; 58(6):556-65. PubMed ID: 25944427
[TBL] [Abstract][Full Text] [Related]
15. Mesorectal pathologic assessment in two grades predicts accurately recurrence, positive circumferential margin, and correlates with survival.
Lino-Silva LS; García-Gómez MA; Aguilar-Romero JM; Domínguez-Rodríguez JA; Salcedo-Hernández RA; Loaeza-Belmont R; Ruiz-García EB; Herrera-Gómez Á
J Surg Oncol; 2015 Dec; 112(8):900-6. PubMed ID: 26487289
[TBL] [Abstract][Full Text] [Related]
16. Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients.
Law WL; Chu KW
Ann Surg; 2004 Aug; 240(2):260-8. PubMed ID: 15273550
[TBL] [Abstract][Full Text] [Related]
17. Robotic Resection is a Good Prognostic Factor in Rectal Cancer Compared with Laparoscopic Resection: Long-term Survival Analysis Using Propensity Score Matching.
Kim J; Baek SJ; Kang DW; Roh YE; Lee JW; Kwak HD; Kwak JM; Kim SH
Dis Colon Rectum; 2017 Mar; 60(3):266-273. PubMed ID: 28177988
[TBL] [Abstract][Full Text] [Related]
18. Long-term oncological results after transanal total mesorectal excision for rectal carcinoma.
Hol JC; van Oostendorp SE; Tuynman JB; Sietses C
Tech Coloproctol; 2019 Sep; 23(9):903-911. PubMed ID: 31599385
[TBL] [Abstract][Full Text] [Related]
19. Total mesorectal excision for mid and low rectal cancer: Laparoscopic vs robotic surgery.
Feroci F; Vannucchi A; Bianchi PP; Cantafio S; Garzi A; Formisano G; Scatizzi M
World J Gastroenterol; 2016 Apr; 22(13):3602-10. PubMed ID: 27053852
[TBL] [Abstract][Full Text] [Related]
20. Local recurrence after mesorectal excision for rectal cancer.
Nesbakken A; Nygaard K; Westerheim O; Mala T; Lunde OC
Eur J Surg Oncol; 2002 Mar; 28(2):126-34. PubMed ID: 11884047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
